8-K 1 form8k.htm FORM 8-K DATED OCTOBER 27, 2011

Standard Industrial Classification Code 3826

  

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15 (D)

of the

SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported):  October 27, 2011

Arrayit Corporation

(Exact name of registrant as specified in its charter)

NEVADA

(State or other jurisdiction of incorporation or organization)

 

33-119586	76-0600966
(Commission File Number)	(IRS Employer Identification Number)

524 East Weddell Drive

Sunnyvale, CA  94089

(Address of principal executive offices)

Rene A. Schena

524 East Weddell Drive

Sunnyvale, CA  94089

(Name and address of agent for service)

408-744-1711

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o	Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

Item 1.  Legal Proceedings.

SUNNYVALE, California – October 27, 2011 – Arrayit Corporation (OTCBB: ARYC) announces that as of October 27, 2011 the litigation between its wholly owned subsidiary, TeleChem International, Inc., and Pediatrix Screening, Inc. et al. has been settled without financial penalty to either party.

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Arrayit Corporation
Date:  October 27, 2011	By: /s/ Rene A. Schena
	Name: Rene A. Schena Title: Chief Executive Officer